Aijun Li
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pituitary Gland Disorders and Treatments
Papers in
-
- Intracranial Aneurysms: Treatment and Complications 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Co-authors
- Weiping Zhou (2 shared papers)Siyuan Fu (1 shared paper)Jianping Zhou (1 shared paper)Meng-Chao Wu (1 shared paper)Wan Yee Lau (1 shared paper)Eric C. H. Lai (1 shared paper)Ze‐Ya Pan (1 shared paper)Tao You Zhou (2 shared papers)
In The Last Decade
Aijun Li
10 papers receiving 403 citations
Peers
Comparison fields: 5 of 46
- Hepatology 174
- Endocrinology, Diabetes and Metabolism 89
- Epidemiology 114
- Cancer Research 21
- Genetics 15
Countries citing papers authored by Aijun Li
This map shows the geographic impact of Aijun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Li more than expected).
Fields of papers citing papers by Aijun Li
This network shows the impact of papers produced by Aijun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Li. The network helps show where Aijun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Aijun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 171 | |
| 2 | 2017 | 115 | |
| 3 | 2010 | 105 | |
| 4 | 2020 | 6 | |
| 5 | 2023 | 5 | |
| 6 | 2016 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2025 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2024 | 0 |
About Aijun Li
Aijun Li is a scholar working on Neurology, Hepatology, Analytical Chemistry, Hematology and Pollution, having authored 12 papers that have together received 410 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (1 paper), 14-3-3 protein interactions (1 paper), Mercury impact and mitigation studies (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Pituitary Gland Disorders and Treatments (1 paper), Intracranial Aneurysms: Treatment and Complications (1 paper), Heavy Metals in Plants (1 paper) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Hepatology (174 citations), Endocrinology, Diabetes and Metabolism (89 citations), Epidemiology (114 citations), Cancer Research (21 citations) and Genetics (15 citations). Aijun Li has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Weiping Zhou, Siyuan Fu, Jianping Zhou, Meng-Chao Wu, Wan Yee Lau, Eric C. H. Lai, Ze‐Ya Pan, Tao You Zhou, Peicheng Cao and Weisheng Liu. Their work appears in journals such as Frontiers in Neurology, Annals of Surgery, Journal of Asian Natural Products Research, Journal of Hepatology and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.